This announcement is a separate document:
艾德生物：2023年度权益分派实施的公告
Amoy Diagnostics: Announcement on the implementation of the distribution of rights in 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.